US 9163085
Anti-OX40 antibodies and methods of treating cancer
granted A61KA61K2039/505A61P
Quick answer
US patent 9163085 (Anti-OX40 antibodies and methods of treating cancer) held by The Board of Regents of the University of Texas System expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00, A61P37/00